The Ascites market report provides current treatment practices, emerging drugs, Ascites market share of the individual therapies, and current and forecasted Ascites market size from 2019 to 2032, segmented by seven major markets. The report also covers current Ascites treatment market practices/algorithms and Ascites unmet needs to curate the best of the opportunities and assess the underlying potential of the market.
Key Takeaways from the Ascites Market Report
- According to DelveInsight’s analysis, the market size for ascites across the 7MM is expected to grow with a significant CAGR by 2032.
- In 2020, the total cases of Ascites due to cirrhosis in the 7MM were ~240,700. Malignant Ascites cases are calculated from ovarian cancer, stomach cancer, breast cancer, and colorectal cancer. In 2020, the number of cases of Ascites from these cancers was ~8,500; ~3,500; ~12,650; and ~10,300, respectively, in the US.
- The leading Ascites companies working in the market including Ocelot Bio, Inc., PharmaIN, Grifols Therapeutics LLC, and others.
- Ascites Pipeline Therapies for treatment include OCE-205, PHIN-214 Subcutaneous injection, Albutein 20% Injectable Solution, and others.
Discover which therapies are expected to grab the ascites market share @ Ascites Market Research Report
Ascites Overview
Ascites is characterized by an abnormal accumulation of fluid within the peritoneal cavity, leading to the collection of fluid in the abdominal spaces. When ascites becomes severe, it can cause discomfort and hinder the patient’s ability to move comfortably. Additionally, it has the potential to pave the way for abdominal infections and may result in the movement of fluid into the chest, enveloping the lungs. This condition poses challenges to everyday activities such as eating, drinking, and mobility, and it can also impede normal breathing.
Ascites Epidemiology Segmentation
- Number of Ascites Cases due to Cirrhosis
- Number of Ascites Cases by Malignancies
- Severity-specific Cases of Ascites due to Cirrhosis
Download the report to understand which factors are driving ascites epidemiology trends @ Ascites Epidemiological Insights
Ascites Treatment Market
The management of ascites resulting from cirrhosis involves various approaches, including the use of diuretics, paracentesis, the placement of a transjugular intrahepatic portosystemic shunt (TIPS), and addressing complications such as spontaneous bacterial peritonitis (SBP). For mild and moderate cirrhotic ascites, treatment encompasses dietary sodium restriction, addressing the underlying condition, fluid restriction, diuretic use, and therapeutic paracentesis. In cases of refractory ascites associated with liver cirrhosis, the strategies involve optimizing medical care, performing serial large volume paracenteses, considering TIPS, peritoneovenous shunt, and exploring the option of liver transplantation.
Learn more about the FDA-approved drugs for ascites @ Drugs for Ascites Treatment
Key Ascites Therapies and Companies
- BIV201: BioVie
- OCE-205: Ocelot Bio
Ascites Market Dynamics
The ascites market dynamics are anticipated to change in the coming years. The rise in the patient population with underlying conditions such as liver cirrhosis, alcoholism, kidney or heart failure, malignancy, etc., may contribute to an increase in the incidence of ascites. The growing healthcare activities and campaigns emphasizing the importance of addressing ascites are bolstering the market. The Serum-Ascites Albumin Gradient plays a crucial role in accurately differentiating ascites fluid, achieving a 90% accuracy rate, and successfully identifying the underlying conditions.
To know more about ascites clinical trials, visit @ Ascites Drugs Market
Scope of the Ascites Market Research Report
- Coverage- 7MM
- Ascites Companies- Ocelot Bio, Inc., PharmaIN, Grifols Therapeutics LLC, and others.
- Ascites Pipeline Therapies OCE-205, PHIN-214 Subcutaneous injection, Albutein 20% Injectable Solution, and others.
- Ascites Market Dynamics: Ascites Market Drivers and Barriers
- Ascites Market Access and Reimbursement, Unmet Needs, Future Perspectives
Discover more about ascites drugs in development @ Ascites Clinical Trials
Table of Content
1. Key Insights
2. Executive Summary of Ascites
3. Competitive Intelligence Analysis for Ascites
4. Ascites: Market Overview at a Glance
5. Ascites: Disease Background and Overview
6. Patient Journey
7. Ascites Epidemiology and Patient Population
8. Ascites Treatment Algorithm, Current Treatment, and Medical Practices
9. Ascites Unmet Needs
10. Key Endpoints of Ascites Treatment
11. Ascites Marketed Products
12. Ascites Emerging Therapies
13. Ascites: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Ascites Market Outlook
16. Ascites Market Access and Reimbursement Overview
17. Ascites KOL Views
18. Ascites Market Drivers
19. Ascites Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 9650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/consulting/primary-research-services
Press Release Distributed by ABNewswire.com
To view the original version on ABNewswire visit: Ascites Market Size is expected to witness a major change in the study period 2019-2032, estimates DelveInsight